Emergency Medicine Cardiac Research and Education Group




ACTION Registry
ACTION Registry®–GWTG™ is a national, risk-adjusted, outcomes-based quality improvement program that helps participating facilities measure and improve care for high-risk ACS patients with STEMI and NSTEMI. The result of the collaboration between the two leading national coronary artery disease registries, the NCDR® ACTION Registry® and the American Heart Association (AHA) Get With The GuidelinesSM-CAD Registry, ACTION Registry–GWTG will be the largest, most comprehensive national cardiovascular patient database ever developed by the medical profession.

Combining the strengths of the two programs, ACTION Registry–GWTG will collect a comprehensive set of data elements that provide healthcare professionals and their facilities with the information they need to monitor and improve adherence to the most current, science-based ACC/AHA treatment guidelines. Participation will greatly facilitate quality improvement efforts, optimize clinical care, and improve clinical outcomes for acute coronary syndrome patients.

Visit How To Join to request additional information or to download an enrollment package. Or, visit the ACTION website for more information.






With well over one and a half million combined Emergency Department (ED) visits at EMCREG sites annually, EMCREG-International is ideally positioned to conduct clinical trials quickly and efficiently. Additionally, as academic emergency clinician educators, EMCREG provides an ideal format for educating the emergency medicine community on cutting-edge evidence-based research, and facilitate acceptance and understanding of current treatment guidelines.

The wealth of experience and clinical acumen associated with such a geographically diverse network of veteran clinician researchers has resulted in the development of the consultation arm of EMCREG-International. These consultation efforts are geared toward helping companies understand both the clinical usefulness and obstacles associated with embracing a new diagnostic or treatment technology in the clinical ED setting. The drive to identify and assess new technologies is equally important to the clinicians making up the EMCREG network as it is to the manufacturers of diagnostic and therapeutic modalities.

The ability to consult with such a large number of well known and geographically diverse emergency physicians in a round table discussion setting has proved invaluable to industry efforts to assess the clinical utility of a promising new diagnostic or therapeutic technology. Will a promising technology ultimately be practical in the clinical ED setting in its current form?; What are the practical, clinical and political obstacles to adopting promising new technologies?; and What alterations to a technology or its marketing would allow its utility and acceptance in the ED to be realized? This ability to rapidly organize such an expert panel with minimal effort has proved appealing for companies facing short development timelines.

Please feel free to contact our offices if the idea of a consultation roundtable or collaboration interests your organization.






Legal information

EMCREG™ - International
231 Albert Sabin Way
MSB Suite 1552
Cincinnati, Ohio 45267-0769

Fell free to contact us toll-free at 1-866-4EMCREG (436-2734)



Advanced Search

23 August 2011
8 August 2011
31 May 2011
29 April 2011
24 March 2011
23 February 2011
18 January 2011
18 January 2011
18 January 2011
18 January 2011
20 December 2010
20 December 2010
NEWS ARCHIVES:
©Copyright EMCREG-International™ 2011. All rights reserved